1[1]Bowcock AM,Krueger JG.Getting under the skin:the immunogenetics of psoriasis[J].Nat Rev Immunol,2005,5(9):699-711.
2[2]Numerof RP,Asadullah K.Cytokine and anti-cytokine therapies for psoriasis and atopic dermatitis[J].BioDrugs,2006,20(2):93-103.
3[3]Gaspari AA.Innate and adaptive immunity and the pathophysiology of psoriasis[J].J Am Acad Dermatol,2006,54(3 Suppl 2):S67-80.
4[4]Fiorentino DF,Bond MW,Mosmann TR.Two types of mouse T helper cell.Ⅳ.Th2 clones secrete a factor that inhibits cytokine production by Th1 clones[J].J Exp Med,1989,170(6):2081-2095.
5[5]Pestka S,Krause CD,Sarkar D,et al.Interleukin-10 and related cytokines and receptors[J].Annu Rev Immunol,2004,22:929-979.
7[7]Fickenscher H,Hor S,Kupers H,et al.The interleukin-10 family of cytokines[J].Trends Immunol,2002,23(2):89-96.
8[8]Seifert M,Sterry W,Effenberger E,et al.The antipsoriatic activity of IL-10 is rather caused by effects on peripheral blood cells than by a direct effect on human keratinocytes[J].Arch Dermatol Res,2000,292(4):164-172.
9[9]Asadullah K,Sabat R,Friedrich M,et al.Interleukin-10:an important immunoregulatory cytokine with major impact on psoriasis[J].Curr Drug Targets Inflamm Allergy,2004,3(2):185-192.
